645 related articles for article (PubMed ID: 31252191)
1. Progression of Inflammatory Bowel Diseases Throughout Latin America and the Caribbean: A Systematic Review.
Kotze PG; Underwood FE; Damião AOMC; Ferraz JGP; Saad-Hossne R; Toro M; Iade B; Bosques-Padilla F; Teixeira FV; Juliao-Banos F; Simian D; Ghosh S; Panaccione R; Ng SC; Kaplan GG
Clin Gastroenterol Hepatol; 2020 Feb; 18(2):304-312. PubMed ID: 31252191
[TBL] [Abstract][Full Text] [Related]
2. Clinical differentiation of inflammatory bowel disease (IBD) in Latin America and the Caribbean.
Yamamoto-Furusho JK; Parra-Holguín NN; Juliao-Baños F; Puentes F; López R; Bosques-Padilla F; Torres EA; Nieves-Jimenéz H; Veitia-Velásquez GR; Jara-Alba ML; Bautista S; Piñol-Jimenez FN; Salgado-Rosado P; Villa-Ovalles KC; Abreu-Martinez YA; Borges Z; Davila-Bedoya S; Otoya-Moreno G; Iadé-Vergara B;
Medicine (Baltimore); 2022 Jan; 101(3):e28624. PubMed ID: 35060539
[TBL] [Abstract][Full Text] [Related]
3. BIOLOGICAL THERAPY PENETRATION FOR INFLAMMATORY BOWEL DISEASE IN LATIN AMERICA: CURRENT STATUS AND FUTURE CHALLENGES.
Quaresma AB; Coy CSR; Damião AOMC; Kaplan GG; Kotze PG
Arq Gastroenterol; 2019; 56(3):318-322. PubMed ID: 31633732
[TBL] [Abstract][Full Text] [Related]
4. Suboptimal response to tumor necrosis factor antagonists in inflammatory bowel disease in Latin America: EXPLORE LATAM study.
Balderramo D; Yamamoto-Furusho J; Ponce de León E; de María J; Zubiaurre I; Pedreira S; Lis C; Brion L; de Paula JA
Gastroenterol Hepatol; 2024 Jan; 47(1):51-62. PubMed ID: 37062500
[TBL] [Abstract][Full Text] [Related]
5. Trends in the epidemiology of inflammatory bowel disease in Colombia by demographics and region using a nationally representative claims database and characterization of inflammatory bowel disease phenotype in a case series of Colombian patients.
Juliao-Baños F; Kock J; Arrubla M; Calixto O; Camargo J; Cruz L; Hurtado J; Clavijo A; Donado J; Schwartz S; Abreu MT; Damas OM
Medicine (Baltimore); 2021 Feb; 100(7):e24729. PubMed ID: 33607817
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory Bowel Disease in Latin America: A Systematic Review.
Calderón M; Minckas N; Nuñez S; Ciapponi A
Value Health Reg Issues; 2018 Dec; 17():126-134. PubMed ID: 29936359
[TBL] [Abstract][Full Text] [Related]
7. Latin Americans and US Hispanics show differences in IBD phenotype: a systematic review with meta-analysis.
Avalos DJ; Satiya J; Contreras A; Trivedi S; Alvarado L; Dodoo C; Dwivedi AK; Zuckerman MJ
J Investig Med; 2022 Apr; 70(4):919-933. PubMed ID: 34933995
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of inflammatory bowel disease in South America: A systematic review.
Selvaratnam S; Gullino S; Shim L; Lee E; Lee A; Paramsothy S; Leong RW
World J Gastroenterol; 2019 Dec; 25(47):6866-6875. PubMed ID: 31885427
[TBL] [Abstract][Full Text] [Related]
9. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia.
Mokhtar NM; Nawawi KNM; Verasingam J; Zhiqin W; Sagap I; Azman ZAM; Mazlan L; Hamid HA; Yaacob NY; Rose IM; Den ELN; Wan MS; Raja Ali RA
BMC Public Health; 2019 Jun; 19(Suppl 4):550. PubMed ID: 31196184
[TBL] [Abstract][Full Text] [Related]
10. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review.
Molodecky NA; Soon IS; Rabi DM; Ghali WA; Ferris M; Chernoff G; Benchimol EI; Panaccione R; Ghosh S; Barkema HW; Kaplan GG
Gastroenterology; 2012 Jan; 142(1):46-54.e42; quiz e30. PubMed ID: 22001864
[TBL] [Abstract][Full Text] [Related]
11. EPIDEMIOLOGIC ASPECTS OF INFLAMMATORY BOWEL DISEASE IN THE WESTERN REGION OF MINAS GERAIS STATE.
Martins KR; Araújo JM; Cruz ÁC; Luiz-Ferreira A
Arq Gastroenterol; 2021; 58(3):377-383. PubMed ID: 34705974
[TBL] [Abstract][Full Text] [Related]
12. Real-world disease activity and sociodemographic, clinical and treatment characteristics of moderate-to-severe inflammatory bowel disease in Brazil.
Zaltman C; Parra RS; Sassaki LY; Santana GO; Ferrari MLA; Miszputen SJ; Amarante HMBS; Kaiser Junior RL; Flores C; Catapani WR; Parente JML; Bafutto M; Ramos O; Gonçalves CD; Guimaraes IM; da Rocha JJR; Feitosa MR; Feres O; Saad-Hossne R; Penna FGC; Cunha PFS; Gomes TN; Nones RB; Faria MAG; Parente MPPD; Scotton AS; Caratin RF; Senra J; Chebli JM
World J Gastroenterol; 2021 Jan; 27(2):208-223. PubMed ID: 33510560
[TBL] [Abstract][Full Text] [Related]
13. Global Hospitalization Trends for Crohn's Disease and Ulcerative Colitis in the 21st Century: A Systematic Review With Temporal Analyses.
Buie MJ; Quan J; Windsor JW; Coward S; Hansen TM; King JA; Kotze PG; Gearry RB; Ng SC; Mak JWY; Abreu MT; Rubin DT; Bernstein CN; Banerjee R; Yamamoto-Furusho JK; Panaccione R; Seow CH; Ma C; Underwood FE; Ahuja V; Panaccione N; Shaheen AA; Holroyd-Leduc J; Kaplan GG; ; Balderramo D; Chong VH; Juliao-Baños F; Dutta U; Simadibrata M; Kaibullayeva J; Sun Y; Hilmi I; Raja Ali RA; Paudel MS; Altuwaijri M; Hartono JL; Wei SC; Limsrivilai J; El Ouali S; Vergara BI; Dao VH; Kelly P; Hodges P; Miao Y; Li M
Clin Gastroenterol Hepatol; 2023 Aug; 21(9):2211-2221. PubMed ID: 35863682
[TBL] [Abstract][Full Text] [Related]
14. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
Burisch J
Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
[TBL] [Abstract][Full Text] [Related]
15. Trends in hospitalisation rates for inflammatory bowel disease in western versus newly industrialised countries: a population-based study of countries in the Organisation for Economic Co-operation and Development.
King JA; Underwood FE; Panaccione N; Quan J; Windsor JW; Kotze PG; Ng SC; Ghosh S; Lakatos PL; Jess T; Panaccione R; Seow CH; Ben-Horin S; Burisch J; Colombel JF; Loftus EV; Gearry R; Halfvarson J; Kaplan GG
Lancet Gastroenterol Hepatol; 2019 Apr; 4(4):287-295. PubMed ID: 30765267
[TBL] [Abstract][Full Text] [Related]
16. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.
Ng SC; Shi HY; Hamidi N; Underwood FE; Tang W; Benchimol EI; Panaccione R; Ghosh S; Wu JCY; Chan FKL; Sung JJY; Kaplan GG
Lancet; 2017 Dec; 390(10114):2769-2778. PubMed ID: 29050646
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and treatment of inflammatory bowel disease: First Latin American Consensus of the Pan American Crohn's and Colitis Organisation.
Yamamoto-Furusho JK; Bosques-Padilla F; de-Paula J; Galiano MT; Ibañez P; Juliao F; Kotze PG; Rocha JL; Steinwurz F; Veitia G; Zaltman C
Rev Gastroenterol Mex; 2017; 82(1):46-84. PubMed ID: 27979414
[TBL] [Abstract][Full Text] [Related]
18. Current global trends in the incidence of pediatric-onset inflammatory bowel disease.
Sýkora J; Pomahačová R; Kreslová M; Cvalínová D; Štych P; Schwarz J
World J Gastroenterol; 2018 Jul; 24(25):2741-2763. PubMed ID: 29991879
[TBL] [Abstract][Full Text] [Related]
19. Recent trends in the epidemiology and clinical outcomes of inflammatory bowel disease in South Korea, 2010-2018.
Kim S; Lee HJ; Lee SW; Park S; Koh SJ; Im JP; Kim BG; Han KD; Kim JS
World J Gastroenterol; 2024 Mar; 30(9):1154-1163. PubMed ID: 38577186
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 outcomes in patients with inflammatory bowel diseases in Latin America: Results from SECURE-IBD registry.
Queiroz NSF; Martins CA; Quaresma AB; Hino AAF; Steinwurz F; Ungaro RC; Kotze PG
J Gastroenterol Hepatol; 2021 Nov; 36(11):3033-3040. PubMed ID: 34151470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
